San Francisco-based women’s health clinic Millie has launched perimenopause and menopause care offerings, expanding beyond its maternal healthcare roots to provide comprehensive gynecological services across women’s life stages. The program addresses a growing need as births among women aged 35 and older have risen 50% over the past decade.
The expansion targets women at the intersection of postpartum and perimenopause, a critical but often underserved patient population. For women having children in their late 30s and 40s, childbirth frequently coincides with hormonal changes defining perimenopause, creating challenges that providers often inadequately address.
“Millie was born out of my own near-miss following the birth of my daughter at the age of 39. As I was recovering, I experienced the intersection of postpartum and perimenopause myself,” said Anu Sharma, Founder and CEO of Millie. “It was hard to tell whether my weight gain, sleep disturbances, mood changes, and chronic pain were due to new motherhood or perimenopause.”
The new services include evidence-based treatments for perimenopause and menopause, encompassing hormone therapy, non-hormonal medications, vaginal treatments, and lifestyle strategies for symptom relief. Services are available both in-person and virtually through Millie’s collaborative clinical team of OBGYNs, midwives, women’s health nurse practitioners, and doulas.
“Now, a few years into Millie, we are not only seeing patients come back after having a second baby with us, but also for the health transitions that follow,” said Talia Borgo, Clinical Director and Nurse-Midwife at Millie. “For many of our patients, two momentous phases of life, postpartum and perimenopause, are colliding.”
The expansion follows previous service additions including preconception counseling and gynecology offerings in 2023, which covered annual wellness exams, infection screenings, contraceptives, and miscarriage care. Millie added fertility assessments earlier this year to support patients trying to conceive.
“Too often, reproductive care ends after the postpartum visit, leaving individuals to navigate complex changes alone,” said Dr. Amy Kane, Medical Director and OB-GYN at Millie. “Continuity of care drives better outcomes, which is why Millie stays with patients from conception through the postpartum period and beyond.”
The announcement follows Millie’s $12 million Series A round co-led by TMV and Foreground Capital, with participation from Pivotal Ventures, Ingeborg Investments, and the March of Dimes Innovation Fund. The funding supported opening a second physical clinic in San Jose as the company expands its California presence.
Millie operates a hybrid model combining digital platforms, physical clinics, and health system partnerships. Since launching in September 2022, the company has served over 2,200 patients through its midwifery-led care approach, offering services from conception through postpartum and now extending to perimenopause and menopause.
